Arsenic methylation, GSTO1 polymorphisms, and metabolic syndrome in an arseniasis endemic area of southwestern Taiwan
- PMID: 22440634
- DOI: 10.1016/j.chemosphere.2012.02.059
Arsenic methylation, GSTO1 polymorphisms, and metabolic syndrome in an arseniasis endemic area of southwestern Taiwan
Abstract
Previous studies have shown that hair arsenic (As) levels are associated with an increased prevalence of metabolic syndrome (MetS), which is a strong predictor for type 2 diabetes. The objective of this study was to evaluate whether urinary arsenic methylation is related to MetS in an arseniasis endemic area of southwestern Taiwan, taking genetic factors into account. Subjects were from a community-based cohort recruited in 1990 from three villages in Putai Township. In 2002-2003, we successfully followed 247 subjects and measured their urinary arsenic species including inorganic arsenic, monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA), as well as the coding region polymorphisms of three genes known to involve in arsenic methylation. Results showed that subjects of MetS had a history of consuming well water of higher arsenic concentration as compared to those without MetS. We also found a significant association between urinary arsenic species and risk for MetS, where the odds ratio of MetS was increased with decreasing proportion of MMA and low rate of primary methylation (defined as MMA/inorganic As). The increased risk associated with low primary methylation rate was further modified by the GSTO1 A140D polymorphism, with the D allele carriers showing a slightly higher risk for MetS. Our results suggest that a low MMA% is associated with increased risk for MetS among As-exposed subjects and the genetic polymorphism of GSTO1, an enzyme responsible for the reduction of pentavalent arsenic species, may also play a modest modification role.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan.Toxicol Appl Pharmacol. 2007 Jan 15;218(2):135-42. doi: 10.1016/j.taap.2006.10.022. Epub 2006 Oct 28. Toxicol Appl Pharmacol. 2007. PMID: 17173945
-
Polymorphisms in arsenic metabolism genes, urinary arsenic methylation profile and cancer.Cancer Causes Control. 2009 Nov;20(9):1653-61. doi: 10.1007/s10552-009-9413-0. Epub 2009 Aug 13. Cancer Causes Control. 2009. PMID: 19680750
-
Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.Sci Total Environ. 2009 Apr 1;407(8):2608-14. doi: 10.1016/j.scitotenv.2008.12.061. Epub 2009 Feb 1. Sci Total Environ. 2009. PMID: 19187952
-
AS3MT, GSTO, and PNP polymorphisms: impact on arsenic methylation and implications for disease susceptibility.Environ Res. 2014 Jul;132:156-67. doi: 10.1016/j.envres.2014.03.012. Epub 2014 May 8. Environ Res. 2014. PMID: 24792412 Review.
-
Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity.Toxicol Lett. 2000 Mar 15;112-113:209-17. doi: 10.1016/s0378-4274(99)00271-4. Toxicol Lett. 2000. PMID: 10720733 Review.
Cited by
-
Update of the risk assessment of inorganic arsenic in food.EFSA J. 2024 Jan 18;22(1):e8488. doi: 10.2903/j.efsa.2024.8488. eCollection 2024 Jan. EFSA J. 2024. PMID: 38239496 Free PMC article.
-
Arsenic in Drinking Water and Diabetes.Water (Basel). 2023 May 1;15(9):1751. doi: 10.3390/w15091751. Epub 2023 May 2. Water (Basel). 2023. PMID: 37886432 Free PMC article.
-
Association between arsenic (+3 oxidation state) methyltransferase gene polymorphisms and arsenic methylation capacity in rural residents of northern China: a cross-sectional study.Arch Toxicol. 2023 Nov;97(11):2919-2928. doi: 10.1007/s00204-023-03590-5. Epub 2023 Sep 2. Arch Toxicol. 2023. PMID: 37658865
-
Association between Heavy Metals, Metalloids and Metabolic Syndrome: New Insights and Approaches.Toxics. 2023 Aug 3;11(8):670. doi: 10.3390/toxics11080670. Toxics. 2023. PMID: 37624175 Free PMC article. Review.
-
Is Arsenic Exposure a Risk Factor for Metabolic Syndrome? A Review of the Potential Mechanisms.Front Endocrinol (Lausanne). 2022 May 16;13:878280. doi: 10.3389/fendo.2022.878280. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35651975 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous